How do CCBs and ARBs compare in the management of hypertension? Should there be a preference for one over the other or should we consider combining them? These are the topics addressed by Professor Luis M Ruilope.
Optimising management of hypertension: use of calcium channel blockers (CCBs) vs. ARBs and use of CCB/ARB combination therapy. In the first part of this video, Professor Ruilope compares the MoAs of CCBs and ARBs therapies and addresses whether any differences in efficacy and tolerability have been observed between the two classes.
Optimising management of hypertension: use of calcium channel blockers (CCBs) vs. ARBs and use of CCB/ARB combination therapy. In this second part, Professor Ruilope discusses the clinical evidence for combining CCBs and ARBs therapies and whether this leads to protection of the cardiovascular and renal systems simultaneously.
Alternatively login via
Back to epgonline.org